These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 30632282)
21. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma. Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838 [TBL] [Abstract][Full Text] [Related]
22. The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection. van Wijk L; de Klein GW; Kanters MA; Patijn GA; Klaase JM Eur J Med Res; 2020 Oct; 25(1):46. PubMed ID: 33028394 [TBL] [Abstract][Full Text] [Related]
23. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection. Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893 [TBL] [Abstract][Full Text] [Related]
24. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer]. Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284 [TBL] [Abstract][Full Text] [Related]
25. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma. Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163 [TBL] [Abstract][Full Text] [Related]
26. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
27. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829 [TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA. Shen Y; Wang H; Li W; Chen J J Clin Lab Anal; 2019 Nov; 33(9):e22999. PubMed ID: 31418936 [TBL] [Abstract][Full Text] [Related]
29. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. Tingle SJ; Severs GR; Goodfellow M; Moir JA; White SA J Surg Oncol; 2018 Sep; 118(4):680-686. PubMed ID: 30196571 [TBL] [Abstract][Full Text] [Related]
30. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma. Fang LP; Xu XY; Ji Y; Huang PW World J Surg; 2018 Nov; 42(11):3736-3745. PubMed ID: 30014292 [TBL] [Abstract][Full Text] [Related]
31. Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer. Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y Pancreatology; 2020 Mar; 20(2):239-246. PubMed ID: 31862230 [TBL] [Abstract][Full Text] [Related]
32. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer. Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer. Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study. Huang YY; Liu X; Liang SH; Hu Y; Ma GW BMC Cancer; 2022 Nov; 22(1):1183. PubMed ID: 36397047 [TBL] [Abstract][Full Text] [Related]
36. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728 [TBL] [Abstract][Full Text] [Related]
37. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer. Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977 [TBL] [Abstract][Full Text] [Related]
38. Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG). Panni RZ; Lopez-Aguiar AG; Liu J; Poultsides GA; Rocha FG; Hawkins WG; Strasberg SM; Trikalinos NA; Maithel S; Fields RC; J Surg Oncol; 2019 Sep; 120(4):632-638. PubMed ID: 31339198 [TBL] [Abstract][Full Text] [Related]
39. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Zhang W; Liu K; Ye B; Liang W; Ren Y Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777 [TBL] [Abstract][Full Text] [Related]
40. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]